General Information of Drug Transporter (DT)
DT ID DTD0452 Transporter Info
Gene Name SLC6A2
Protein Name Sodium-dependent noradrenaline transporter
Gene ID
6530
UniProt ID
P23975
Genetic Polymorphisms of DT (GPD)
Genetic Polymorphism rs12708954
Site of GPD chr16:55697687 (GRCh38.p12)
GPD Type SNP
Allele(s) in dbSNP C>A
Minor Allele Frequency A=0.1853/928 (Global)
 Allele A Click to Show/Hide the Full List of Affected Drugs:            1 Drugs in Total
Atomoxetine Drug Info Attention Deficit Disorder With Hyperactivity Correlated with the increased drug response in patients (compare with allele C) [ 1]
Genetic Polymorphism rs2242446
Site of GPD chr16:55656513 (GRCh38.p12)
GPD Type SNP
Allele(s) in dbSNP C>A / C>T
Minor Allele Frequency C=0.2470/1237 (Global)
 Genotype CC Click to Show/Hide the Full List of Affected Drugs:            1 Drugs in Total
Venlafaxine Drug Info Major Depressive Disorder Correlated with the increased drug response in patients (compare with Genotypes CT + TT) [ 2]
 Genotype TT Click to Show/Hide the Full List of Affected Drugs:            1 Drugs in Total
3,4-Methylenedioxymethamphetamine Drug Info Posttraumatic Stress Disorder Correlated with the decreased drug response (compare with genotypes CC + CT) [ 3]
Genetic Polymorphism rs36029
Site of GPD chr16:55662844 (GRCh38.p12)
GPD Type SNP
Allele(s) in dbSNP A>G
Minor Allele Frequency G=0.3978/1992 (Global)
 Genotype AA Click to Show/Hide the Full List of Affected Drugs:            1 Drugs in Total
3,4-Methylenedioxymethamphetamine Drug Info Posttraumatic Stress Disorder Correlated with the increased drug response in patients (compare with genotypes AG + GG) [ 3]
Genetic Polymorphism rs3785143
Site of GPD chr16:55661194 (GRCh38.p12)
GPD Type SNP
Allele(s) in dbSNP C>T
Minor Allele Frequency T=0.1048/525 (Global)
 Allele T Click to Show/Hide the Full List of Affected Drugs:            1 Drugs in Total
Atomoxetine Drug Info Attention Deficit Disorder With Hyperactivity Correlated with the decreased drug response in patients (compare with allele C) [ 4]
Genetic Polymorphism rs5569
Site of GPD chr16:55697923 (GRCh38.p12)
GPD Type SNP
Allele(s) in dbSNP G>A / G>C
Minor Allele Frequency A=0.2334/1169 (Global)
 Allele A Click to Show/Hide the Full List of Affected Drugs:            1 Drugs in Total
Methylphenidate Drug Info Attention Deficit Disorder With Hyperactivity Irrelevant to the drug response in patients (compare with Allele G) [ 5]
 Genotype GG Click to Show/Hide the Full List of Affected Drugs:            1 Drugs in Total
Methylphenidate Drug Info Attention Deficit Disorder With Hyperactivity Correlated with the increased drug response in patients (compare with genotypes AA + AG) [ 6]
Genetic Polymorphism rs1861647
Site of GPD chr16:55694494 (GRCh38.p12)
GPD Type SNP
Allele(s) in dbSNP G>A / G>C
Minor Allele Frequency A=0.2384/1194 (Global)
 Genotype GG Click to Show/Hide the Full List of Affected Drugs:            1 Drugs in Total
3,4-Methylenedioxymethamphetamine Drug Info Posttraumatic Stress Disorder Correlated with the increased drug response (compare with genotypes AA + AG) [ 3]
References
1 A haplotype of the norepinephrine transporter (Net) gene Slc6a2 is associated with clinical response to atomoxetine in attention-deficit hyperactivity disorder (ADHD). Neuropsychopharmacology. 2009 Aug;34(9):2135-42.
2 Norepinephrine Transporter Gene Variants and Remission From Depression With Venlafaxine Treatment in Older Adults. Am J Psychiatry. 2017 May 1;174(5):468-475.
3 No major role of norepinephrine transporter gene variations in the cardiostimulant effects of MDMA. Eur J Clin Pharmacol. 2018 Mar;74(3):275-283.
4 Adrenergic neurotransmitter system transporter and receptor genes associated with atomoxetine response in attention-deficit hyperactivity disorder children. J Neural Transm (Vienna). 2013 Jul;120(7):1127-33.
5 Lack of association between response of OROS-methylphenidate and norepinephrine transporter (SLC6A2) polymorphism in Korean ADHD. Psychiatry Res. 2011 Apr 30;186(2-3):338-44.
6 Norepinephrine transporter gene (SLC6A2) is involved with methylphenidate response in Korean children with attention deficit hyperactivity disorder. Int Clin Psychopharmacol. 2011 Mar;26(2):107-13.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.